Irritable Bowel Syndrome (IBS)
Also known as: IBS, Spastic Colon, Nervous Stomach, Irritable colon, IBS-C, IBS-D
IBS is a common functional gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits without identifiable structural abnormality. It is classified as IBS-C (constipation), IBS-D (diarrhea), or IBS-M (mixed). While not life-threatening, IBS significantly affects quality of life.
Last updated October 31, 2026
Understanding Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome is a disorder of gut-brain interaction: the bowel looks normal on scans, scopes and biopsies, yet it hurts, cramps and empties unpredictably. It is defined by recurrent abdominal pain tied to bowel movements, with a change in stool frequency or form, present for at least six months. Roughly one adult in ten meets the criteria, most are diagnosed before 50, and women are affected about twice as often as men. The subtype matters for treatment: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D) or mixed (IBS-M). IBS does not shorten life or lead to cancer or inflammatory bowel disease, but it is one of the commonest reasons for lost workdays and repeat doctor visits, and its effect on daily life is routinely underestimated.
Several things go wrong at once. The nerves lining the gut become oversensitive, so normal amounts of gas and stretch register as pain (visceral hypersensitivity), and the brain regions that process that signal become more alert to it. Motility is uncoordinated: the colon may contract too strongly after meals in IBS-D or too sluggishly in IBS-C. In many people the trigger was a bout of gastroenteritis; about one in ten develops post-infectious IBS, with low-grade immune activation, extra mast cells near gut nerves and a leakier lining. Bile acid malabsorption explains up to a quarter of IBS-D. The microbiome is shifted toward gas-producing species, one reason fermentable carbohydrates (FODMAPs) drive bloating. Serotonin, mostly made in the gut, modulates all of this, which is why drugs acting on serotonin receptors work.
IBS waxes and wanes over years; about a third of people are symptom-free at any one time, but relapse is the rule. Conventional care is stepped. First-line measures are regular meals, soluble fiber, a trial of the low-FODMAP diet and antispasmodics such as hyoscine or dicyclomine, with loperamide for diarrhea and polyethylene glycol for constipation. Second-line drugs target the subtype: linaclotide, plecanatide, lubiprostone or tenapanor for IBS-C; rifaximin, eluxadoline or alosetron for IBS-D. Rifaximin, a non-absorbed antibiotic, gave adequate relief in 41% versus 32% on placebo across two 14-day trials, a modest but real gain. Low-dose tricyclics such as amitriptyline 10 to 30 mg at night act as gut-brain neuromodulators rather than antidepressants at those doses, and the 2023 ATLANTIS trial in primary care showed a meaningful advantage over placebo at six months. Cognitive behavioral therapy and gut-directed hypnotherapy perform as well as most drugs.
Natural approaches are not fringe here; several sit inside the ACG and British guidelines. Enteric-coated peppermint oil is the best studied, with a 2019 pooled analysis of 12 trials giving a number needed to treat of about three for global symptoms. Psyllium, not bran, is the fiber that helps. Probiotics help some people, but the effect is strain-specific and modest, and the research is messy enough that guidelines stop short of naming a product. Curcumin and glutamine each have a single good trial. The nine-herb bitter mixture STW5 (Iberogast), not covered in our library, improved pain versus placebo in a 208-patient four-week trial and is widely prescribed in Germany. The honest picture is that diet, soluble fiber and peppermint oil are a reasonable first move for mild to moderate IBS, with medication layered on when that is not enough.
The thing most people get wrong is treating IBS as a food allergy to be hunted down. Endless elimination diets rarely find a single culprit, shrink the diet and the microbiome, and can tip into disordered eating; one survey found a third of IBS patients avoiding more than five food groups. The low-FODMAP diet is designed as a four-to-eight-week test with structured reintroduction, after which most people tolerate most foods in moderate amounts. Equally, being told it is just stress misses the point: stress amplifies a sensitised gut, but the sensitivity itself is physical and treatable.
At a Glance
- Common symptoms
- Recurrent abdominal pain associated with bowel movements, Bloating and abdominal distension, Alternating diarrhea and constipation
- Main treatments
- Dietary modifications: low-FODMAP diet, increased fiber for IBS-C, Antispasmodic medications, Laxatives for IBS-C or anti-diarrheals for IBS-D
- Category
- Digestive · Affects approximately 10–15% of the global population
- See a doctor if
- Symptoms significantly interfere with daily life
Symptoms
Causes
- Gut-brain axis dysfunction
- Visceral hypersensitivity
- Altered gut motility
- Intestinal microbiome imbalances
- Post-infectious IBS following gastroenteritis
- Psychological factors including stress and anxiety
Risk Factors
- Female sex (twice as common in women)
- Age under 50
- Family history of IBS
- History of anxiety, depression, or emotional trauma
- Previous gastrointestinal infection
Diagnosis
- Rome IV criteria assessment
- Exclusion of alarm features (weight loss, bleeding, anemia)
- Blood tests including CBC, CRP, and celiac serology
- Stool tests to rule out infection and inflammation
- Colonoscopy if alarm features are present or patient is over 45
Treatment
- Dietary modifications: low-FODMAP diet, increased fiber for IBS-C
- Antispasmodic medications
- Laxatives for IBS-C or anti-diarrheals for IBS-D
- Prescription medications: linaclotide for IBS-C; rifaximin for IBS-D
- Low-dose tricyclic antidepressants or SSRIs for pain modulation
- Cognitive behavioral therapy and gut-directed hypnotherapy
Natural remedies for irritable bowel syndrome (ibs): what the evidence says
Ranked by the strength of human evidence for irritable bowel syndrome (ibs) specifically. These sit alongside medical care, not in place of it.
Peppermint oil (enteric-coated)
Strong evidenceA 2019 meta-analysis of 12 randomized trials (835 patients) found enteric-coated peppermint oil roughly doubled the odds of global improvement, with a number needed to treat of about 3 for overall symptoms and 4 for pain. Trials ran 2 to 12 weeks using 180 to 225 mg capsules two or three times daily. The oil relaxes gut smooth muscle via calcium channels and dampens TRPM8 pain receptors.
- Studied dose
- 180 to 225 mg enteric-coated capsule, 2 to 3 times daily before meals, for 4 to 12 weeks.
- Cautions
- Can worsen heartburn by relaxing the lower esophageal sphincter; swallow capsules whole and not with antacids, which dissolve the coating early. Avoid in children under 8 and with bile duct obstruction. May raise cyclosporine levels.
Psyllium husk
Strong evidenceMeta-analyses show soluble fiber (psyllium, ispaghula) improves global IBS symptoms with a number needed to treat of about 7, while insoluble bran does not help and often worsens bloating. In a 275-patient primary-care trial, 10 g of psyllium twice daily gave adequate relief in 57% versus 35% on placebo over the first month. Its gel softens stool in IBS-C and firms it in IBS-D.
- Studied dose
- 3.5 to 5 g in a large glass of water once daily, building to twice daily over 2 weeks (10 to 20 g per day in trials).
- Cautions
- Early bloating is common and settles. Take 2 hours apart from lithium, carbamazepine, digoxin and levothyroxine, whose absorption it can reduce. Not for anyone with swallowing difficulty or suspected obstruction; always with plenty of fluid.
Lactobacillus probiotics (strain-specific)
Moderate evidenceA 2018 meta-analysis of 53 trials (5,545 patients) found probiotics as a class reduced persistent symptoms (relative risk 0.81, number needed to treat 7) but with high heterogeneity. Lactobacillus plantarum 299v at 10 billion CFU daily for four weeks reduced pain and bloating in a 214-patient trial, with 78% rating it good or excellent versus 8% on placebo; other Lactobacillus strains have been negative.
- Studied dose
- L. plantarum 299v, 10 billion CFU once daily; judge response at 8 to 12 weeks and stop if no benefit.
- Cautions
- Avoid live probiotics in severe immunosuppression, with a central venous line, or in acute pancreatitis, where rare bloodstream infections have occurred. Some people get more bloating in the first week.
Bifidobacterium strains
Moderate evidenceBifidobacterium infantis 35624 at 100 million CFU daily for four weeks improved pain, bloating and a composite score versus placebo in a 362-woman trial. B. bifidum MIMBb75 (1 billion CFU, 4 weeks, 122 patients) had 47% responders versus 11%, and a heat-inactivated version replicated this in 443 patients (34% versus 19%). These are the most consistent single-strain results in IBS.
- Studied dose
- B. infantis 35624, 100 million CFU daily, or B. bifidum MIMBb75, 1 billion CFU daily, for 4 to 8 weeks.
- Cautions
- Same precautions as other live probiotics. Look for the exact strain code on the label; a generic Bifidobacterium blend has not been shown to do the same thing.
Partially hydrolyzed guar gum (PHGG)
Moderate evidenceIn a 188-patient 12-week trial, 5 g of PHGG daily improved IBS symptoms as much as 30 g of wheat bran but was far better tolerated, and more patients chose to continue it. A later 121-patient trial using 6 g daily for 12 weeks reduced bloating and improved stool consistency in both IBS-C and IBS-D. It is fully soluble and non-gelling, so it rarely bloats.
- Studied dose
- 5 to 6 g once daily dissolved in water or food, for at least 4 weeks.
- Cautions
- Mild gas in the first week. Separate from medications by 2 hours and drink enough fluid. Safe in pregnancy at food-level doses.
Curcumin (turmeric extract)
Moderate evidenceA 2018 meta-analysis of five randomized trials found curcumin products improved IBS symptom scores versus placebo, though trials were small and preparations varied. The best gave 121 patients curcumin 42 mg plus fennel oil 25 mg twice daily for 30 days: symptom severity fell by 50 points versus 26 on placebo, and 26% became symptom-free versus 7%. Absorption is poor, so formulation matters.
- Studied dose
- Curcumin-fennel oil 42 mg/25 mg twice daily, or a bioavailable curcumin extract 500 mg twice daily with food, for 4 to 8 weeks.
- Cautions
- Mild antiplatelet effect; caution with warfarin, apixaban or clopidogrel and stop 2 weeks before surgery. Avoid with gallstones or bile duct obstruction. Piperine-enhanced products raise levels of several drugs.
L-glutamine
Preliminary evidenceA single well-designed trial gave 106 people with post-infectious IBS-D 5 g of glutamine three times daily or placebo for eight weeks: 80% of the glutamine group had a 50-point or greater fall in symptom severity versus 6% on placebo, and raised intestinal permeability normalized. Striking, but unreplicated and specific to IBS that began after an infection.
- Studied dose
- 5 g powder in water three times daily with meals for 8 weeks, as studied.
- Cautions
- Avoid in significant liver or kidney disease and hepatic encephalopathy. Theoretical interaction with anticonvulsants; discuss if you have epilepsy. Not studied in pregnancy at this dose.
What matters day to day
- Run the low-FODMAP diet as a structured experiment, ideally with a dietitian: 50 to 75% of people respond within 4 weeks, but restriction should end by week 8, with reintroduction to find your real triggers.
- Move regularly: in a 12-week trial, 20 to 60 minutes of moderate exercise 3 to 5 times a week improved symptom scores in 43% of people versus 26% of controls, and the benefit held at 5-year follow-up.
- Eat at regular times and do not skip meals; the colon contracts most after eating (the gastrocolic reflex), and erratic timing makes motility more unpredictable.
- Treat the brain side directly: telephone-delivered CBT cut symptom severity by about 60 points more than usual care at 12 months in the 558-patient ACTIB trial, and six sessions of gut-directed hypnotherapy gave adequate relief in roughly 40% versus 17% for education alone.
- Limit alcohol, caffeine and large fatty meals, each of which triggers stronger colonic contractions within an hour of consumption.
Prevention
- Identify and avoid food triggers
- Eat regular, balanced meals
- Exercise regularly
- Manage stress through mindfulness or therapy
When to See a Doctor
- Symptoms significantly interfere with daily life
- You experience weight loss, rectal bleeding, or persistent vomiting
- Symptoms begin after age 50
- Family history of colorectal cancer or IBD
Frequently Asked Questions
References
- Lacy BE, Pimentel M, Brenner DM, et al.. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology (2021)
- Alammar N, Wang L, Saberi B, et al.. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complementary and Alternative Medicine (2019)
- Bijkerk CJ, de Wit NJ, Muris JW, et al.. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ (2009)
- Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics (2018)
- Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2014)
- Zhou Q, Verne ML, Fields JZ, et al.. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut (2019)
- Portincasa P, Bonfrate L, Scribano ML, et al.. Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. Journal of Gastrointestinal and Liver Diseases (2016)
- Pimentel M, Lembo A, Chey WD, et al.. Rifaximin therapy for patients with irritable bowel syndrome without constipation. New England Journal of Medicine (2011)
- Madisch A, Holtmann G, Plein K, Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Alimentary Pharmacology and Therapeutics (2004)
- Irritable Bowel Syndrome (IBS). National Institute of Diabetes and Digestive and Kidney DiseasesView source
Related Conditions
Lab tests that relate to irritable bowel syndrome (ibs)
Related from the Supplement Library
Peppermint
StrongHerb · Relieves IBS symptoms (pain, bloating, transit)
Probiotics (Lactobacillus)
StrongProbiotic · Gut microbiome balance and diversity
Psyllium Husk
StrongCompound · Promotes digestive regularity
L-Glutamine
ModerateAmino Acid · Gut lining repair and intestinal integrity
Slippery Elm
PreliminaryHerb · GI tract soothing and protection
Kefir
ModerateProbiotic · Delivers diverse probiotic bacteria and yeasts
These supplements have been studied in relation to Irritable Bowel Syndrome (IBS). Always consult your healthcare provider before starting any supplement, especially if you take medications.
Related Reading
Have questions about Irritable Bowel Syndrome (IBS)?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.